Development and commercialization of cell transplantation product for the treatment of equine tendon tendinopathy

Project facts

Project promoter:
InCell Ltd.
Project Number:
LV06-0004
Target groups
Entrepreneurs
Status:
Completed
Initial project cost:
€107,731
Final project cost:
€55,127
From Norway Grants:
€ 42,171
The project is carried out in:
Rīga

Description

The aim of the project is to develop a standardized cell transplantation product for regeneration of horse tendons. The new production method offers a significantly reduced use of resources and it is energy efficient. In obtaining transplantation products, the most significant amount of resources is used in the process of cell extraction from the tissues but the new production method reduces the number of these processes. Namely, instead of more than 2000 extraction processes (currently available products), only one process is performed that is necessary to create allogeneic cell bank. In addition the new method allows to use less reagents and materials necessary in the cell processing, the production of which takes a significant amount of energy resources. The project implementation will allow the new company to develop a product that will be unique to the veterinary medicine market. In the result of the project innovative packaging technology will be developed that ensure a number of advantages in cell transplantation procedures. The project will be developed within the Green Technology incubator.

Summary of project results

Norway Grants have supported the project in veterinary industry. Latvian startup company Incell developed the product production process and a convenient product packaging for the veterinarian that allows avoiding additional manipulations during the cell injection procedure in a case of sport horses injures. Product packaging and possibility to perform asepctic injection now makes it more safe for use with a visiting clinic (vehicles equipped with medical equipment) on the spot at the horse stand, allowing to reduce expenses for transporting horses to / from clinic and allowing to ensure treatment with the new product in a short period of time for a larger number of horses. The product is attractive for the target clients as it offers a high efficiency that is achieved through minimum number of manipulations. Owners of horses are considered the end users, who, as a result of the product use, will be able to reduce the duration of the downtime of the injured horses (up to 50%) and the related losses and expenses. The new product contains a set of unique features that are not characteristic of any of the products currently available in the market. The total eligible costs of the project - 55127 euro, Norway grant aid –48455 euro.

Summary of bilateral results